Clinical Trial

Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV.
Protocol Amendment History 3 changes
critical Trial status changed: RECRUITING → ACTIVE_NOT_RECRUITING 2026-07-21
notable Primary completion moved earlier: 2028-09-26 -> 2027-07-18 2026-07-21
minor Completion moved earlier: 2028-09-26 -> 2027-07-18 2026-07-21
Trial Details
NCT Number NCT06321601
Lead Sponsor Amgen
Conditions Vasculitis
Enrollment 19 participants
Start Date 2024-10-22
Primary Completion 2027-07-18 (estimated)
Study Completion 2027-07-18 (estimated)
Updated on ClinicalTrials.gov 2026-07-20